z-logo
open-access-imgOpen Access
LTBK-01: PROSPECTIVE, MULTI-CENTER PHASE III TRIAL OF TUMOR TREATING FIELDS TOGETHER WITH TEMOZOLOMIDE COMPARED TO TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
Author(s) -
Roger Stupp,
Ahmed Idbaïh,
David M. Steinberg,
William L. Read,
Steven A. Toms,
Gene H. Barnett,
Garth Nicholas,
ChaeYong Kim,
Karen Fink,
Andrea Salmaggi,
Frank S. Lieberman,
Jay Zhu,
Lynne P. Taylor,
Giuseppe Stragliotto,
Andreas F. Hottinger,
Eilon D. Kirson,
Uri Weinberg,
Yoram Palti,
Monika E. Hegi,
Zvi Ram
Publication year - 2016
Publication title -
neuro-oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.005
H-Index - 125
eISSN - 1523-5866
pISSN - 1522-8517
DOI - 10.1093/neuonc/now260
Subject(s) - temozolomide , glioblastoma , medicine , oncology , center (category theory) , cancer research , chemistry , crystallography

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom